Taste alterations are not classified among the most frequently reported adverse effects of Mounjaro in clinical trials or post-marketing surveillance data
Pharmacological PINK1 activation ameliorates Pathology in Parkinsons Disease models
Fatigue can also have multiple causes in people taking GLP-1 medications, including reduced caloric intake, which makes attribution complex
Track food intake and consider dietitian guidance for personalized meal planning
If you are taking Ozempic, Wegovy, Mounjaro or another GLP-1 medication, speak with your prescribing doctor or a dietitian before changing your diet or adding any new supplement
Value-Based Agreements for GLP-1 Anti-Obesity Medicines in Medicare Antiobesity medicines (AOMs), including GLP1 agonists, offer substantial promise for curbing chronic disease in the U.S